nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—PTGS2—Alzheimer's disease	0.363	1	CbGaD
Betamethasone—CYP3A4—Rivastigmine—Alzheimer's disease	0.0711	0.432	CbGbCtD
Betamethasone—CYP3A4—Donepezil—Alzheimer's disease	0.0568	0.345	CbGbCtD
Betamethasone—CYP3A4—Galantamine—Alzheimer's disease	0.0366	0.223	CbGbCtD
Betamethasone—PLA2G1B—blood vessel—Alzheimer's disease	0.00862	0.155	CbGeAlD
Betamethasone—PGR—blood vessel—Alzheimer's disease	0.00397	0.0712	CbGeAlD
Betamethasone—PLA2G1B—nervous system—Alzheimer's disease	0.00247	0.0443	CbGeAlD
Betamethasone—PLA2G1B—central nervous system—Alzheimer's disease	0.00238	0.0426	CbGeAlD
Betamethasone—NR3C2—forebrain—Alzheimer's disease	0.00225	0.0404	CbGeAlD
Betamethasone—NR3C2—telencephalon—Alzheimer's disease	0.00207	0.0371	CbGeAlD
Betamethasone—PTGS2—blood vessel—Alzheimer's disease	0.00198	0.0355	CbGeAlD
Betamethasone—PLA2G1B—brain—Alzheimer's disease	0.00189	0.0338	CbGeAlD
Betamethasone—CYP19A1—forebrain—Alzheimer's disease	0.00188	0.0338	CbGeAlD
Betamethasone—NR3C1—embryo—Alzheimer's disease	0.00137	0.0245	CbGeAlD
Betamethasone—ABCB1—blood vessel—Alzheimer's disease	0.00123	0.022	CbGeAlD
Betamethasone—NR3C2—nervous system—Alzheimer's disease	0.00122	0.0219	CbGeAlD
Betamethasone—NR3C1—forebrain—Alzheimer's disease	0.00121	0.0217	CbGeAlD
Betamethasone—PTGS2—embryo—Alzheimer's disease	0.00118	0.0212	CbGeAlD
Betamethasone—NR3C2—central nervous system—Alzheimer's disease	0.00118	0.0211	CbGeAlD
Betamethasone—NR3C2—cerebellum—Alzheimer's disease	0.00115	0.0206	CbGeAlD
Betamethasone—PGR—nervous system—Alzheimer's disease	0.00114	0.0204	CbGeAlD
Betamethasone—NR3C1—telencephalon—Alzheimer's disease	0.00111	0.0199	CbGeAlD
Betamethasone—PGR—central nervous system—Alzheimer's disease	0.00109	0.0196	CbGeAlD
Betamethasone—PGR—cerebellum—Alzheimer's disease	0.00107	0.0192	CbGeAlD
Betamethasone—PTGS2—forebrain—Alzheimer's disease	0.00105	0.0187	CbGeAlD
Betamethasone—CYP19A1—nervous system—Alzheimer's disease	0.00102	0.0183	CbGeAlD
Betamethasone—CYP19A1—central nervous system—Alzheimer's disease	0.000985	0.0177	CbGeAlD
Betamethasone—PTGS2—telencephalon—Alzheimer's disease	0.000962	0.0172	CbGeAlD
Betamethasone—NR3C2—brain—Alzheimer's disease	0.000935	0.0168	CbGeAlD
Betamethasone—PGR—brain—Alzheimer's disease	0.000869	0.0156	CbGeAlD
Betamethasone—Eye pain—Rivastigmine—Alzheimer's disease	0.000867	0.00291	CcSEcCtD
Betamethasone—Psychotic disorder—Donepezil—Alzheimer's disease	0.00086	0.00289	CcSEcCtD
Betamethasone—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.000859	0.00289	CcSEcCtD
Betamethasone—Increased appetite—Memantine—Alzheimer's disease	0.000851	0.00286	CcSEcCtD
Betamethasone—Injury—Rivastigmine—Alzheimer's disease	0.000851	0.00286	CcSEcCtD
Betamethasone—Irritability—Donepezil—Alzheimer's disease	0.000841	0.00283	CcSEcCtD
Betamethasone—Dermatitis bullous—Memantine—Alzheimer's disease	0.000837	0.00281	CcSEcCtD
Betamethasone—Mood swings—Donepezil—Alzheimer's disease	0.000834	0.00281	CcSEcCtD
Betamethasone—Increased appetite—Rivastigmine—Alzheimer's disease	0.000833	0.0028	CcSEcCtD
Betamethasone—Cardiac failure—Memantine—Alzheimer's disease	0.00082	0.00276	CcSEcCtD
Betamethasone—Dermatitis bullous—Rivastigmine—Alzheimer's disease	0.000819	0.00275	CcSEcCtD
Betamethasone—Lethargy—Memantine—Alzheimer's disease	0.000816	0.00274	CcSEcCtD
Betamethasone—Dry skin—Donepezil—Alzheimer's disease	0.000807	0.00272	CcSEcCtD
Betamethasone—Cardiac failure—Rivastigmine—Alzheimer's disease	0.000802	0.0027	CcSEcCtD
Betamethasone—Hypokalaemia—Donepezil—Alzheimer's disease	0.000802	0.0027	CcSEcCtD
Betamethasone—Bradycardia—Galantamine—Alzheimer's disease	0.0008	0.00269	CcSEcCtD
Betamethasone—Osteoarthritis—Memantine—Alzheimer's disease	0.0008	0.00269	CcSEcCtD
Betamethasone—Haemoglobin—Galantamine—Alzheimer's disease	0.00079	0.00266	CcSEcCtD
Betamethasone—Affect lability—Memantine—Alzheimer's disease	0.000787	0.00265	CcSEcCtD
Betamethasone—Haemorrhage—Galantamine—Alzheimer's disease	0.000786	0.00264	CcSEcCtD
Betamethasone—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.000782	0.00263	CcSEcCtD
Betamethasone—Hallucination—Galantamine—Alzheimer's disease	0.000782	0.00263	CcSEcCtD
Betamethasone—CYP19A1—brain—Alzheimer's disease	0.000782	0.014	CbGeAlD
Betamethasone—Psychotic disorder—Memantine—Alzheimer's disease	0.000781	0.00263	CcSEcCtD
Betamethasone—Muscular weakness—Donepezil—Alzheimer's disease	0.000777	0.00261	CcSEcCtD
Betamethasone—Migraine—Rivastigmine—Alzheimer's disease	0.00077	0.00259	CcSEcCtD
Betamethasone—Affect lability—Rivastigmine—Alzheimer's disease	0.00077	0.00259	CcSEcCtD
Betamethasone—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.000764	0.00257	CcSEcCtD
Betamethasone—Irritability—Memantine—Alzheimer's disease	0.000763	0.00257	CcSEcCtD
Betamethasone—Cardiac arrest—Memantine—Alzheimer's disease	0.00076	0.00256	CcSEcCtD
Betamethasone—Visual impairment—Galantamine—Alzheimer's disease	0.000758	0.00255	CcSEcCtD
Betamethasone—Mood swings—Memantine—Alzheimer's disease	0.000758	0.00255	CcSEcCtD
Betamethasone—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.000744	0.0025	CcSEcCtD
Betamethasone—Sweating increased—Donepezil—Alzheimer's disease	0.000742	0.00249	CcSEcCtD
Betamethasone—Mood swings—Rivastigmine—Alzheimer's disease	0.000741	0.00249	CcSEcCtD
Betamethasone—Eye disorder—Galantamine—Alzheimer's disease	0.000735	0.00247	CcSEcCtD
Betamethasone—Dry skin—Memantine—Alzheimer's disease	0.000733	0.00247	CcSEcCtD
Betamethasone—ABCB1—embryo—Alzheimer's disease	0.000731	0.0131	CbGeAlD
Betamethasone—Hypokalaemia—Memantine—Alzheimer's disease	0.000728	0.00245	CcSEcCtD
Betamethasone—Dry skin—Rivastigmine—Alzheimer's disease	0.000717	0.00241	CcSEcCtD
Betamethasone—Angiopathy—Galantamine—Alzheimer's disease	0.000713	0.0024	CcSEcCtD
Betamethasone—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.000712	0.00239	CcSEcCtD
Betamethasone—Muscular weakness—Memantine—Alzheimer's disease	0.000705	0.00237	CcSEcCtD
Betamethasone—Arrhythmia—Galantamine—Alzheimer's disease	0.000702	0.00236	CcSEcCtD
Betamethasone—Weight increased—Donepezil—Alzheimer's disease	0.000693	0.00233	CcSEcCtD
Betamethasone—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00069	0.00232	CcSEcCtD
Betamethasone—Weight decreased—Donepezil—Alzheimer's disease	0.000689	0.00232	CcSEcCtD
Betamethasone—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000687	0.00231	CcSEcCtD
Betamethasone—Sweating increased—Memantine—Alzheimer's disease	0.000673	0.00226	CcSEcCtD
Betamethasone—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000669	0.00225	CcSEcCtD
Betamethasone—Myocardial infarction—Donepezil—Alzheimer's disease	0.000665	0.00224	CcSEcCtD
Betamethasone—Conjunctivitis—Donepezil—Alzheimer's disease	0.00066	0.00222	CcSEcCtD
Betamethasone—Sweating increased—Rivastigmine—Alzheimer's disease	0.000659	0.00222	CcSEcCtD
Betamethasone—NR3C1—nervous system—Alzheimer's disease	0.000656	0.0118	CbGeAlD
Betamethasone—ABCB1—forebrain—Alzheimer's disease	0.000647	0.0116	CbGeAlD
Betamethasone—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000635	0.00214	CcSEcCtD
Betamethasone—NR3C1—central nervous system—Alzheimer's disease	0.000632	0.0113	CbGeAlD
Betamethasone—Weight increased—Memantine—Alzheimer's disease	0.000629	0.00212	CcSEcCtD
Betamethasone—Weight decreased—Memantine—Alzheimer's disease	0.000625	0.0021	CcSEcCtD
Betamethasone—Hyperglycaemia—Memantine—Alzheimer's disease	0.000624	0.0021	CcSEcCtD
Betamethasone—Bradycardia—Donepezil—Alzheimer's disease	0.00062	0.00209	CcSEcCtD
Betamethasone—NR3C1—cerebellum—Alzheimer's disease	0.000617	0.0111	CbGeAlD
Betamethasone—Malaise—Galantamine—Alzheimer's disease	0.000617	0.00208	CcSEcCtD
Betamethasone—Weight increased—Rivastigmine—Alzheimer's disease	0.000615	0.00207	CcSEcCtD
Betamethasone—Vertigo—Galantamine—Alzheimer's disease	0.000615	0.00207	CcSEcCtD
Betamethasone—Syncope—Galantamine—Alzheimer's disease	0.000614	0.00206	CcSEcCtD
Betamethasone—Haemoglobin—Donepezil—Alzheimer's disease	0.000612	0.00206	CcSEcCtD
Betamethasone—Weight decreased—Rivastigmine—Alzheimer's disease	0.000612	0.00206	CcSEcCtD
Betamethasone—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00061	0.00205	CcSEcCtD
Betamethasone—Haemorrhage—Donepezil—Alzheimer's disease	0.000609	0.00205	CcSEcCtD
Betamethasone—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000608	0.00204	CcSEcCtD
Betamethasone—Hallucination—Donepezil—Alzheimer's disease	0.000606	0.00204	CcSEcCtD
Betamethasone—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000604	0.00203	CcSEcCtD
Betamethasone—Myocardial infarction—Memantine—Alzheimer's disease	0.000604	0.00203	CcSEcCtD
Betamethasone—Loss of consciousness—Galantamine—Alzheimer's disease	0.000602	0.00202	CcSEcCtD
Betamethasone—Conjunctivitis—Memantine—Alzheimer's disease	0.000599	0.00201	CcSEcCtD
Betamethasone—ABCB1—telencephalon—Alzheimer's disease	0.000595	0.0107	CbGeAlD
Betamethasone—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000594	0.002	CcSEcCtD
Betamethasone—Convulsion—Galantamine—Alzheimer's disease	0.000593	0.00199	CcSEcCtD
Betamethasone—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000591	0.00199	CcSEcCtD
Betamethasone—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000591	0.00199	CcSEcCtD
Betamethasone—Hypertension—Galantamine—Alzheimer's disease	0.000591	0.00199	CcSEcCtD
Betamethasone—Visual impairment—Donepezil—Alzheimer's disease	0.000587	0.00198	CcSEcCtD
Betamethasone—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000586	0.00197	CcSEcCtD
Betamethasone—Myalgia—Galantamine—Alzheimer's disease	0.000583	0.00196	CcSEcCtD
Betamethasone—Anxiety—Galantamine—Alzheimer's disease	0.000581	0.00195	CcSEcCtD
Betamethasone—Discomfort—Galantamine—Alzheimer's disease	0.000576	0.00194	CcSEcCtD
Betamethasone—PTGS2—nervous system—Alzheimer's disease	0.000568	0.0102	CbGeAlD
Betamethasone—Bradycardia—Memantine—Alzheimer's disease	0.000563	0.00189	CcSEcCtD
Betamethasone—Haemoglobin—Memantine—Alzheimer's disease	0.000556	0.00187	CcSEcCtD
Betamethasone—Haemorrhage—Memantine—Alzheimer's disease	0.000553	0.00186	CcSEcCtD
Betamethasone—Bradycardia—Rivastigmine—Alzheimer's disease	0.000551	0.00185	CcSEcCtD
Betamethasone—Hallucination—Memantine—Alzheimer's disease	0.000551	0.00185	CcSEcCtD
Betamethasone—Shock—Galantamine—Alzheimer's disease	0.00055	0.00185	CcSEcCtD
Betamethasone—Nervous system disorder—Galantamine—Alzheimer's disease	0.000548	0.00184	CcSEcCtD
Betamethasone—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000547	0.00184	CcSEcCtD
Betamethasone—PTGS2—central nervous system—Alzheimer's disease	0.000547	0.0098	CbGeAlD
Betamethasone—Tachycardia—Galantamine—Alzheimer's disease	0.000545	0.00183	CcSEcCtD
Betamethasone—Arrhythmia—Donepezil—Alzheimer's disease	0.000544	0.00183	CcSEcCtD
Betamethasone—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000544	0.00183	CcSEcCtD
Betamethasone—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000541	0.00182	CcSEcCtD
Betamethasone—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00054	0.00182	CcSEcCtD
Betamethasone—Hallucination—Rivastigmine—Alzheimer's disease	0.000539	0.00181	CcSEcCtD
Betamethasone—Alopecia—Donepezil—Alzheimer's disease	0.000538	0.00181	CcSEcCtD
Betamethasone—PTGS2—cerebellum—Alzheimer's disease	0.000534	0.00958	CbGeAlD
Betamethasone—Visual impairment—Memantine—Alzheimer's disease	0.000533	0.00179	CcSEcCtD
Betamethasone—Anorexia—Galantamine—Alzheimer's disease	0.000532	0.00179	CcSEcCtD
Betamethasone—Erythema—Donepezil—Alzheimer's disease	0.00053	0.00178	CcSEcCtD
Betamethasone—Hypotension—Galantamine—Alzheimer's disease	0.000522	0.00176	CcSEcCtD
Betamethasone—Visual impairment—Rivastigmine—Alzheimer's disease	0.000522	0.00175	CcSEcCtD
Betamethasone—Eye disorder—Memantine—Alzheimer's disease	0.000517	0.00174	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000509	0.00171	CcSEcCtD
Betamethasone—Eye disorder—Rivastigmine—Alzheimer's disease	0.000506	0.0017	CcSEcCtD
Betamethasone—Insomnia—Galantamine—Alzheimer's disease	0.000505	0.0017	CcSEcCtD
Betamethasone—Angiopathy—Memantine—Alzheimer's disease	0.000502	0.00169	CcSEcCtD
Betamethasone—Paraesthesia—Galantamine—Alzheimer's disease	0.000502	0.00169	CcSEcCtD
Betamethasone—NR3C1—brain—Alzheimer's disease	0.000501	0.00899	CbGeAlD
Betamethasone—CYP3A4—nervous system—Alzheimer's disease	0.000496	0.00889	CbGeAlD
Betamethasone—Arrhythmia—Memantine—Alzheimer's disease	0.000494	0.00166	CcSEcCtD
Betamethasone—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000492	0.00166	CcSEcCtD
Betamethasone—Dyspepsia—Galantamine—Alzheimer's disease	0.000492	0.00165	CcSEcCtD
Betamethasone—Angiopathy—Rivastigmine—Alzheimer's disease	0.000491	0.00165	CcSEcCtD
Betamethasone—Alopecia—Memantine—Alzheimer's disease	0.000489	0.00164	CcSEcCtD
Betamethasone—Decreased appetite—Galantamine—Alzheimer's disease	0.000486	0.00163	CcSEcCtD
Betamethasone—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000484	0.00163	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000482	0.00162	CcSEcCtD
Betamethasone—Fatigue—Galantamine—Alzheimer's disease	0.000482	0.00162	CcSEcCtD
Betamethasone—Malaise—Donepezil—Alzheimer's disease	0.000478	0.00161	CcSEcCtD
Betamethasone—Alopecia—Rivastigmine—Alzheimer's disease	0.000478	0.00161	CcSEcCtD
Betamethasone—CYP3A4—central nervous system—Alzheimer's disease	0.000478	0.00856	CbGeAlD
Betamethasone—Vertigo—Donepezil—Alzheimer's disease	0.000477	0.0016	CcSEcCtD
Betamethasone—Syncope—Donepezil—Alzheimer's disease	0.000476	0.0016	CcSEcCtD
Betamethasone—Erythema—Rivastigmine—Alzheimer's disease	0.000471	0.00158	CcSEcCtD
Betamethasone—Loss of consciousness—Donepezil—Alzheimer's disease	0.000466	0.00157	CcSEcCtD
Betamethasone—Feeling abnormal—Galantamine—Alzheimer's disease	0.00046	0.00155	CcSEcCtD
Betamethasone—Convulsion—Donepezil—Alzheimer's disease	0.00046	0.00155	CcSEcCtD
Betamethasone—Hypertension—Donepezil—Alzheimer's disease	0.000458	0.00154	CcSEcCtD
Betamethasone—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000457	0.00154	CcSEcCtD
Betamethasone—Myalgia—Donepezil—Alzheimer's disease	0.000452	0.00152	CcSEcCtD
Betamethasone—Anxiety—Donepezil—Alzheimer's disease	0.00045	0.00151	CcSEcCtD
Betamethasone—Ill-defined disorder—Memantine—Alzheimer's disease	0.000447	0.0015	CcSEcCtD
Betamethasone—Discomfort—Donepezil—Alzheimer's disease	0.000446	0.0015	CcSEcCtD
Betamethasone—Body temperature increased—Galantamine—Alzheimer's disease	0.000442	0.00149	CcSEcCtD
Betamethasone—Abdominal pain—Galantamine—Alzheimer's disease	0.000442	0.00149	CcSEcCtD
Betamethasone—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000437	0.00147	CcSEcCtD
Betamethasone—Malaise—Memantine—Alzheimer's disease	0.000434	0.00146	CcSEcCtD
Betamethasone—PTGS2—brain—Alzheimer's disease	0.000434	0.00778	CbGeAlD
Betamethasone—Oedema—Donepezil—Alzheimer's disease	0.000433	0.00146	CcSEcCtD
Betamethasone—Vertigo—Memantine—Alzheimer's disease	0.000433	0.00146	CcSEcCtD
Betamethasone—Syncope—Memantine—Alzheimer's disease	0.000432	0.00145	CcSEcCtD
Betamethasone—Infection—Donepezil—Alzheimer's disease	0.00043	0.00145	CcSEcCtD
Betamethasone—Shock—Donepezil—Alzheimer's disease	0.000426	0.00143	CcSEcCtD
Betamethasone—Malaise—Rivastigmine—Alzheimer's disease	0.000425	0.00143	CcSEcCtD
Betamethasone—Nervous system disorder—Donepezil—Alzheimer's disease	0.000425	0.00143	CcSEcCtD
Betamethasone—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000424	0.00143	CcSEcCtD
Betamethasone—Vertigo—Rivastigmine—Alzheimer's disease	0.000423	0.00142	CcSEcCtD
Betamethasone—Loss of consciousness—Memantine—Alzheimer's disease	0.000423	0.00142	CcSEcCtD
Betamethasone—Syncope—Rivastigmine—Alzheimer's disease	0.000423	0.00142	CcSEcCtD
Betamethasone—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000419	0.00141	CcSEcCtD
Betamethasone—Convulsion—Memantine—Alzheimer's disease	0.000417	0.0014	CcSEcCtD
Betamethasone—Hypertension—Memantine—Alzheimer's disease	0.000416	0.0014	CcSEcCtD
Betamethasone—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000414	0.00139	CcSEcCtD
Betamethasone—Anorexia—Donepezil—Alzheimer's disease	0.000413	0.00139	CcSEcCtD
Betamethasone—Myalgia—Memantine—Alzheimer's disease	0.00041	0.00138	CcSEcCtD
Betamethasone—Anxiety—Memantine—Alzheimer's disease	0.000409	0.00137	CcSEcCtD
Betamethasone—Convulsion—Rivastigmine—Alzheimer's disease	0.000408	0.00137	CcSEcCtD
Betamethasone—Hypertension—Rivastigmine—Alzheimer's disease	0.000407	0.00137	CcSEcCtD
Betamethasone—Discomfort—Memantine—Alzheimer's disease	0.000405	0.00136	CcSEcCtD
Betamethasone—Hypotension—Donepezil—Alzheimer's disease	0.000405	0.00136	CcSEcCtD
Betamethasone—Myalgia—Rivastigmine—Alzheimer's disease	0.000401	0.00135	CcSEcCtD
Betamethasone—Asthenia—Galantamine—Alzheimer's disease	0.000401	0.00135	CcSEcCtD
Betamethasone—Anxiety—Rivastigmine—Alzheimer's disease	0.0004	0.00134	CcSEcCtD
Betamethasone—Discomfort—Rivastigmine—Alzheimer's disease	0.000396	0.00133	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000394	0.00133	CcSEcCtD
Betamethasone—Oedema—Memantine—Alzheimer's disease	0.000393	0.00132	CcSEcCtD
Betamethasone—Insomnia—Donepezil—Alzheimer's disease	0.000392	0.00132	CcSEcCtD
Betamethasone—Infection—Memantine—Alzheimer's disease	0.000391	0.00131	CcSEcCtD
Betamethasone—Paraesthesia—Donepezil—Alzheimer's disease	0.000389	0.00131	CcSEcCtD
Betamethasone—Shock—Memantine—Alzheimer's disease	0.000387	0.0013	CcSEcCtD
Betamethasone—Nervous system disorder—Memantine—Alzheimer's disease	0.000385	0.0013	CcSEcCtD
Betamethasone—Thrombocytopenia—Memantine—Alzheimer's disease	0.000385	0.00129	CcSEcCtD
Betamethasone—Oedema—Rivastigmine—Alzheimer's disease	0.000385	0.00129	CcSEcCtD
Betamethasone—Tachycardia—Memantine—Alzheimer's disease	0.000384	0.00129	CcSEcCtD
Betamethasone—Diarrhoea—Galantamine—Alzheimer's disease	0.000382	0.00129	CcSEcCtD
Betamethasone—Infection—Rivastigmine—Alzheimer's disease	0.000382	0.00128	CcSEcCtD
Betamethasone—Dyspepsia—Donepezil—Alzheimer's disease	0.000381	0.00128	CcSEcCtD
Betamethasone—Hyperhidrosis—Memantine—Alzheimer's disease	0.00038	0.00128	CcSEcCtD
Betamethasone—Shock—Rivastigmine—Alzheimer's disease	0.000378	0.00127	CcSEcCtD
Betamethasone—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000377	0.00127	CcSEcCtD
Betamethasone—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000377	0.00127	CcSEcCtD
Betamethasone—Decreased appetite—Donepezil—Alzheimer's disease	0.000376	0.00127	CcSEcCtD
Betamethasone—Tachycardia—Rivastigmine—Alzheimer's disease	0.000375	0.00126	CcSEcCtD
Betamethasone—Anorexia—Memantine—Alzheimer's disease	0.000375	0.00126	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000374	0.00126	CcSEcCtD
Betamethasone—Fatigue—Donepezil—Alzheimer's disease	0.000373	0.00126	CcSEcCtD
Betamethasone—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000372	0.00125	CcSEcCtD
Betamethasone—Pain—Donepezil—Alzheimer's disease	0.00037	0.00125	CcSEcCtD
Betamethasone—Dizziness—Galantamine—Alzheimer's disease	0.000369	0.00124	CcSEcCtD
Betamethasone—Hypotension—Memantine—Alzheimer's disease	0.000367	0.00124	CcSEcCtD
Betamethasone—Anorexia—Rivastigmine—Alzheimer's disease	0.000367	0.00123	CcSEcCtD
Betamethasone—Hypotension—Rivastigmine—Alzheimer's disease	0.000359	0.00121	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000358	0.0012	CcSEcCtD
Betamethasone—Feeling abnormal—Donepezil—Alzheimer's disease	0.000357	0.0012	CcSEcCtD
Betamethasone—Insomnia—Memantine—Alzheimer's disease	0.000356	0.0012	CcSEcCtD
Betamethasone—Vomiting—Galantamine—Alzheimer's disease	0.000355	0.00119	CcSEcCtD
Betamethasone—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000354	0.00119	CcSEcCtD
Betamethasone—Paraesthesia—Memantine—Alzheimer's disease	0.000353	0.00119	CcSEcCtD
Betamethasone—Rash—Galantamine—Alzheimer's disease	0.000352	0.00118	CcSEcCtD
Betamethasone—Dermatitis—Galantamine—Alzheimer's disease	0.000352	0.00118	CcSEcCtD
Betamethasone—ABCB1—nervous system—Alzheimer's disease	0.000351	0.00629	CbGeAlD
Betamethasone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00035	0.00118	CcSEcCtD
Betamethasone—Headache—Galantamine—Alzheimer's disease	0.00035	0.00118	CcSEcCtD
Betamethasone—Insomnia—Rivastigmine—Alzheimer's disease	0.000348	0.00117	CcSEcCtD
Betamethasone—Dyspepsia—Memantine—Alzheimer's disease	0.000346	0.00116	CcSEcCtD
Betamethasone—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000345	0.00116	CcSEcCtD
Betamethasone—Urticaria—Donepezil—Alzheimer's disease	0.000344	0.00116	CcSEcCtD
Betamethasone—Body temperature increased—Donepezil—Alzheimer's disease	0.000342	0.00115	CcSEcCtD
Betamethasone—Abdominal pain—Donepezil—Alzheimer's disease	0.000342	0.00115	CcSEcCtD
Betamethasone—Decreased appetite—Memantine—Alzheimer's disease	0.000342	0.00115	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000339	0.00114	CcSEcCtD
Betamethasone—Fatigue—Memantine—Alzheimer's disease	0.000339	0.00114	CcSEcCtD
Betamethasone—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000339	0.00114	CcSEcCtD
Betamethasone—ABCB1—central nervous system—Alzheimer's disease	0.000338	0.00606	CbGeAlD
Betamethasone—Pain—Memantine—Alzheimer's disease	0.000336	0.00113	CcSEcCtD
Betamethasone—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000334	0.00112	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000332	0.00112	CcSEcCtD
Betamethasone—Nausea—Galantamine—Alzheimer's disease	0.000332	0.00112	CcSEcCtD
Betamethasone—Fatigue—Rivastigmine—Alzheimer's disease	0.000332	0.00112	CcSEcCtD
Betamethasone—ABCB1—cerebellum—Alzheimer's disease	0.00033	0.00592	CbGeAlD
Betamethasone—Pain—Rivastigmine—Alzheimer's disease	0.000329	0.00111	CcSEcCtD
Betamethasone—Feeling abnormal—Memantine—Alzheimer's disease	0.000324	0.00109	CcSEcCtD
Betamethasone—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000321	0.00108	CcSEcCtD
Betamethasone—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000317	0.00107	CcSEcCtD
Betamethasone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000314	0.00106	CcSEcCtD
Betamethasone—Urticaria—Memantine—Alzheimer's disease	0.000312	0.00105	CcSEcCtD
Betamethasone—Body temperature increased—Memantine—Alzheimer's disease	0.000311	0.00105	CcSEcCtD
Betamethasone—Abdominal pain—Memantine—Alzheimer's disease	0.000311	0.00105	CcSEcCtD
Betamethasone—Asthenia—Donepezil—Alzheimer's disease	0.000311	0.00104	CcSEcCtD
Betamethasone—Pruritus—Donepezil—Alzheimer's disease	0.000306	0.00103	CcSEcCtD
Betamethasone—Urticaria—Rivastigmine—Alzheimer's disease	0.000305	0.00103	CcSEcCtD
Betamethasone—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000304	0.00102	CcSEcCtD
Betamethasone—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000304	0.00102	CcSEcCtD
Betamethasone—Diarrhoea—Donepezil—Alzheimer's disease	0.000296	0.000996	CcSEcCtD
Betamethasone—Dizziness—Donepezil—Alzheimer's disease	0.000286	0.000963	CcSEcCtD
Betamethasone—Asthenia—Memantine—Alzheimer's disease	0.000282	0.000949	CcSEcCtD
Betamethasone—Pruritus—Memantine—Alzheimer's disease	0.000278	0.000935	CcSEcCtD
Betamethasone—Asthenia—Rivastigmine—Alzheimer's disease	0.000276	0.000928	CcSEcCtD
Betamethasone—Vomiting—Donepezil—Alzheimer's disease	0.000275	0.000926	CcSEcCtD
Betamethasone—Rash—Donepezil—Alzheimer's disease	0.000273	0.000918	CcSEcCtD
Betamethasone—Dermatitis—Donepezil—Alzheimer's disease	0.000273	0.000917	CcSEcCtD
Betamethasone—Pruritus—Rivastigmine—Alzheimer's disease	0.000272	0.000915	CcSEcCtD
Betamethasone—Headache—Donepezil—Alzheimer's disease	0.000271	0.000912	CcSEcCtD
Betamethasone—Diarrhoea—Memantine—Alzheimer's disease	0.000269	0.000905	CcSEcCtD
Betamethasone—Triamcinolone—BCHE—Alzheimer's disease	0.000269	0.272	CrCbGaD
Betamethasone—ABCB1—brain—Alzheimer's disease	0.000268	0.00481	CbGeAlD
Betamethasone—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000263	0.000885	CcSEcCtD
Betamethasone—Fluoxymesterone—ESR1—Alzheimer's disease	0.00026	0.264	CrCbGaD
Betamethasone—Dizziness—Memantine—Alzheimer's disease	0.00026	0.000874	CcSEcCtD
Betamethasone—Nausea—Donepezil—Alzheimer's disease	0.000257	0.000865	CcSEcCtD
Betamethasone—Dizziness—Rivastigmine—Alzheimer's disease	0.000254	0.000855	CcSEcCtD
Betamethasone—Vomiting—Memantine—Alzheimer's disease	0.00025	0.000841	CcSEcCtD
Betamethasone—Rash—Memantine—Alzheimer's disease	0.000248	0.000834	CcSEcCtD
Betamethasone—Dermatitis—Memantine—Alzheimer's disease	0.000248	0.000833	CcSEcCtD
Betamethasone—Headache—Memantine—Alzheimer's disease	0.000246	0.000828	CcSEcCtD
Betamethasone—Vomiting—Rivastigmine—Alzheimer's disease	0.000245	0.000822	CcSEcCtD
Betamethasone—Rash—Rivastigmine—Alzheimer's disease	0.000242	0.000815	CcSEcCtD
Betamethasone—Dermatitis—Rivastigmine—Alzheimer's disease	0.000242	0.000815	CcSEcCtD
Betamethasone—Headache—Rivastigmine—Alzheimer's disease	0.000241	0.00081	CcSEcCtD
Betamethasone—Nausea—Memantine—Alzheimer's disease	0.000233	0.000785	CcSEcCtD
Betamethasone—Nausea—Rivastigmine—Alzheimer's disease	0.000228	0.000768	CcSEcCtD
Betamethasone—Dexamethasone—NOS2—Alzheimer's disease	0.000205	0.208	CrCbGaD
Betamethasone—Triamcinolone—PTGS2—Alzheimer's disease	0.000124	0.125	CrCbGaD
Betamethasone—Dexamethasone—CYP2D6—Alzheimer's disease	7.02e-05	0.0711	CrCbGaD
Betamethasone—Dexamethasone—PTGS2—Alzheimer's disease	5.9e-05	0.0597	CrCbGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	4.45e-05	0.000378	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NPY—Alzheimer's disease	4.45e-05	0.000378	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—IL6—Alzheimer's disease	4.45e-05	0.000378	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IAPP—Alzheimer's disease	4.42e-05	0.000375	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—TPI1—Alzheimer's disease	4.39e-05	0.000373	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CHAT—Alzheimer's disease	4.39e-05	0.000373	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TNF—Alzheimer's disease	4.36e-05	0.00037	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SNCA—Alzheimer's disease	4.35e-05	0.000369	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	4.34e-05	0.000368	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—IL6—Alzheimer's disease	4.3e-05	0.000365	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CRH—Alzheimer's disease	4.3e-05	0.000364	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	4.26e-05	0.000362	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CA4—Alzheimer's disease	4.26e-05	0.000361	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PPARG—Alzheimer's disease	4.26e-05	0.000361	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—MAOB—Alzheimer's disease	4.21e-05	0.000357	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—INS—Alzheimer's disease	4.18e-05	0.000354	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	4.08e-05	0.000346	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.07e-05	0.000345	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NPS—Alzheimer's disease	4.07e-05	0.000345	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GAPDH—Alzheimer's disease	4.06e-05	0.000344	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PPP3CA—Alzheimer's disease	4.05e-05	0.000344	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—ESR1—Alzheimer's disease	4.02e-05	0.000341	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	4.01e-05	0.00034	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	4.01e-05	0.00034	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTK2B—Alzheimer's disease	3.99e-05	0.000339	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	3.99e-05	0.000338	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.97e-05	0.000337	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	3.96e-05	0.000336	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—EIF2S1—Alzheimer's disease	3.96e-05	0.000336	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—A2M—Alzheimer's disease	3.92e-05	0.000332	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	3.91e-05	0.000331	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SST—Alzheimer's disease	3.88e-05	0.000329	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GAB2—Alzheimer's disease	3.88e-05	0.000329	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NTRK2—Alzheimer's disease	3.88e-05	0.000329	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	3.88e-05	0.000329	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PSENEN—Alzheimer's disease	3.88e-05	0.000329	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GSK3A—Alzheimer's disease	3.85e-05	0.000327	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TP53—Alzheimer's disease	3.85e-05	0.000326	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APH1A—Alzheimer's disease	3.82e-05	0.000324	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	3.8e-05	0.000322	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APP—Alzheimer's disease	3.79e-05	0.000321	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	3.76e-05	0.000319	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	3.75e-05	0.000318	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NCSTN—Alzheimer's disease	3.72e-05	0.000316	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	3.72e-05	0.000315	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	3.66e-05	0.000311	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—NOS3—Alzheimer's disease	3.66e-05	0.000311	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—PPARG—Alzheimer's disease	3.66e-05	0.000311	CbGpPWpGaD
Betamethasone—PTGS2—Disease—LRP1—Alzheimer's disease	3.63e-05	0.000308	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PLD3—Alzheimer's disease	3.62e-05	0.000307	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PLCB1—Alzheimer's disease	3.57e-05	0.000303	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL6—Alzheimer's disease	3.52e-05	0.000299	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3.51e-05	0.000298	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TPI1—Alzheimer's disease	3.51e-05	0.000297	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.49e-05	0.000296	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	3.47e-05	0.000295	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	3.46e-05	0.000294	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ACHE—Alzheimer's disease	3.41e-05	0.000289	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—INPP5D—Alzheimer's disease	3.37e-05	0.000286	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	3.37e-05	0.000286	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTGS2—Alzheimer's disease	3.35e-05	0.000284	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	3.34e-05	0.000284	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—ESR1—Alzheimer's disease	3.34e-05	0.000284	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NGFR—Alzheimer's disease	3.33e-05	0.000283	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EIF2AK2—Alzheimer's disease	3.3e-05	0.00028	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	3.28e-05	0.000278	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ADAM10—Alzheimer's disease	3.26e-05	0.000276	CbGpPWpGaD
Betamethasone—PTGS2—Disease—GAPDH—Alzheimer's disease	3.24e-05	0.000274	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—NOTCH1—Alzheimer's disease	3.23e-05	0.000274	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ND1—Alzheimer's disease	3.23e-05	0.000274	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.2e-05	0.000271	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ENO1—Alzheimer's disease	3.19e-05	0.000271	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS1—Alzheimer's disease	3.19e-05	0.000271	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	3.18e-05	0.00027	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CYP2D6—Alzheimer's disease	3.13e-05	0.000266	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	3.12e-05	0.000264	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	3.09e-05	0.000262	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—S100B—Alzheimer's disease	3.08e-05	0.000261	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—PPARG—Alzheimer's disease	3.05e-05	0.000259	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PSEN2—Alzheimer's disease	3.03e-05	0.000257	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—BCHE—Alzheimer's disease	2.97e-05	0.000252	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.97e-05	0.000252	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CST3—Alzheimer's disease	2.96e-05	0.000251	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TPI1—Alzheimer's disease	2.94e-05	0.000249	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CHAT—Alzheimer's disease	2.94e-05	0.000249	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IGF2—Alzheimer's disease	2.93e-05	0.000249	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	2.89e-05	0.000245	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IGF1R—Alzheimer's disease	2.83e-05	0.00024	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—MAOB—Alzheimer's disease	2.82e-05	0.000239	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PLCB1—Alzheimer's disease	2.8e-05	0.000238	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IAPP—Alzheimer's disease	2.77e-05	0.000235	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.75e-05	0.000233	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—LPL—Alzheimer's disease	2.72e-05	0.00023	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ABCA1—Alzheimer's disease	2.71e-05	0.00023	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GAPDH—Alzheimer's disease	2.71e-05	0.00023	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MEF2C—Alzheimer's disease	2.69e-05	0.000228	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.68e-05	0.000227	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	2.66e-05	0.000225	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.65e-05	0.000225	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PRKCG—Alzheimer's disease	2.64e-05	0.000224	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.63e-05	0.000223	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—A2M—Alzheimer's disease	2.62e-05	0.000222	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.62e-05	0.000222	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NGF—Alzheimer's disease	2.57e-05	0.000218	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ENO1—Alzheimer's disease	2.55e-05	0.000216	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PPP3CA—Alzheimer's disease	2.53e-05	0.000215	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCR5—Alzheimer's disease	2.5e-05	0.000212	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.47e-05	0.000209	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.45e-05	0.000208	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HTR2A—Alzheimer's disease	2.45e-05	0.000208	CbGpPWpGaD
Betamethasone—PTGS2—Disease—GAB2—Alzheimer's disease	2.43e-05	0.000206	CbGpPWpGaD
Betamethasone—PTGS2—Disease—GSK3A—Alzheimer's disease	2.41e-05	0.000204	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APP—Alzheimer's disease	2.37e-05	0.000201	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.36e-05	0.0002	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.34e-05	0.000199	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PPARGC1A—Alzheimer's disease	2.34e-05	0.000198	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.33e-05	0.000198	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—HMOX1—Alzheimer's disease	2.33e-05	0.000198	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CALM1—Alzheimer's disease	2.29e-05	0.000194	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—LEP—Alzheimer's disease	2.28e-05	0.000193	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APOE—Alzheimer's disease	2.28e-05	0.000193	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ACHE—Alzheimer's disease	2.28e-05	0.000193	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CAV1—Alzheimer's disease	2.26e-05	0.000191	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.25e-05	0.000191	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—INPP5D—Alzheimer's disease	2.25e-05	0.000191	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.23e-05	0.000189	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.21e-05	0.000187	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ESR1—Alzheimer's disease	2.17e-05	0.000184	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—F2—Alzheimer's disease	2.15e-05	0.000182	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	2.14e-05	0.000182	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ENO1—Alzheimer's disease	2.13e-05	0.000181	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PTGS1—Alzheimer's disease	2.13e-05	0.000181	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—LPL—Alzheimer's disease	2.13e-05	0.000181	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.1e-05	0.000178	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOTCH1—Alzheimer's disease	2.1e-05	0.000178	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP2D6—Alzheimer's disease	2.09e-05	0.000177	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TPI1—Alzheimer's disease	2.08e-05	0.000177	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CHAT—Alzheimer's disease	2.08e-05	0.000177	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	2.06e-05	0.000175	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ADAM10—Alzheimer's disease	2.04e-05	0.000173	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—MAOB—Alzheimer's disease	2e-05	0.000169	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.99e-05	0.000169	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—BCHE—Alzheimer's disease	1.98e-05	0.000168	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—AKT1—Alzheimer's disease	1.98e-05	0.000168	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GSK3B—Alzheimer's disease	1.97e-05	0.000167	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CREB1—Alzheimer's disease	1.96e-05	0.000166	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—INS—Alzheimer's disease	1.95e-05	0.000165	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ESR1—Alzheimer's disease	1.93e-05	0.000164	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GAPDH—Alzheimer's disease	1.92e-05	0.000163	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—MTHFR—Alzheimer's disease	1.92e-05	0.000163	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCL2—Alzheimer's disease	1.91e-05	0.000162	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IGF1—Alzheimer's disease	1.88e-05	0.00016	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PLCB1—Alzheimer's disease	1.87e-05	0.000159	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NOTCH1—Alzheimer's disease	1.87e-05	0.000158	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—A2M—Alzheimer's disease	1.86e-05	0.000157	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.85e-05	0.000157	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ABCA1—Alzheimer's disease	1.81e-05	0.000154	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CALM1—Alzheimer's disease	1.79e-05	0.000152	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—APOE—Alzheimer's disease	1.79e-05	0.000151	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CAV1—Alzheimer's disease	1.77e-05	0.00015	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PPARG—Alzheimer's disease	1.76e-05	0.00015	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOS3—Alzheimer's disease	1.71e-05	0.000145	CbGpPWpGaD
Betamethasone—PTGS2—Disease—LPL—Alzheimer's disease	1.7e-05	0.000144	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AKT1—Alzheimer's disease	1.68e-05	0.000143	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PRKCG—Alzheimer's disease	1.65e-05	0.00014	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ACHE—Alzheimer's disease	1.61e-05	0.000137	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—INPP5D—Alzheimer's disease	1.6e-05	0.000135	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.57e-05	0.000133	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CCR5—Alzheimer's disease	1.57e-05	0.000133	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPARGC1A—Alzheimer's disease	1.56e-05	0.000133	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—HMOX1—Alzheimer's disease	1.56e-05	0.000132	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PPARG—Alzheimer's disease	1.56e-05	0.000132	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MTHFR—Alzheimer's disease	1.53e-05	0.00013	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—INS—Alzheimer's disease	1.53e-05	0.000129	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ENO1—Alzheimer's disease	1.51e-05	0.000128	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS1—Alzheimer's disease	1.51e-05	0.000128	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	1.48e-05	0.000126	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CASP3—Alzheimer's disease	1.45e-05	0.000123	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CALM1—Alzheimer's disease	1.43e-05	0.000121	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APOE—Alzheimer's disease	1.42e-05	0.000121	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—LPL—Alzheimer's disease	1.42e-05	0.000121	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CAV1—Alzheimer's disease	1.41e-05	0.00012	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—BCHE—Alzheimer's disease	1.41e-05	0.000119	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—NOS3—Alzheimer's disease	1.34e-05	0.000113	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAPK8—Alzheimer's disease	1.33e-05	0.000113	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOS2—Alzheimer's disease	1.33e-05	0.000113	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PLCB1—Alzheimer's disease	1.33e-05	0.000113	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOTCH1—Alzheimer's disease	1.31e-05	0.000112	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ABCA1—Alzheimer's disease	1.29e-05	0.000109	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.28e-05	0.000109	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.28e-05	0.000109	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—MTHFR—Alzheimer's disease	1.28e-05	0.000109	CbGpPWpGaD
Betamethasone—PTGS2—Disease—GSK3B—Alzheimer's disease	1.23e-05	0.000105	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.23e-05	0.000104	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—Alzheimer's disease	1.23e-05	0.000104	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CREB1—Alzheimer's disease	1.22e-05	0.000104	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS2—Alzheimer's disease	1.22e-05	0.000104	CbGpPWpGaD
Betamethasone—PTGS2—Disease—INS—Alzheimer's disease	1.22e-05	0.000103	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AKT1—Alzheimer's disease	1.21e-05	0.000102	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CALM1—Alzheimer's disease	1.2e-05	0.000102	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APOE—Alzheimer's disease	1.19e-05	0.000101	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.18e-05	0.0001	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CAV1—Alzheimer's disease	1.18e-05	0.0001	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.14e-05	9.69e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TGFB1—Alzheimer's disease	1.13e-05	9.57e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	1.11e-05	9.4e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HMOX1—Alzheimer's disease	1.1e-05	9.36e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOS3—Alzheimer's disease	1.07e-05	9.05e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPARG—Alzheimer's disease	1.04e-05	8.81e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—INS—Alzheimer's disease	1.02e-05	8.65e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—LPL—Alzheimer's disease	1.01e-05	8.56e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ACHE—Alzheimer's disease	9.94e-06	8.43e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	9.83e-06	8.34e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	9.32e-06	7.9e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ENO1—Alzheimer's disease	9.32e-06	7.9e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—Alzheimer's disease	9.29e-06	7.88e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	9.14e-06	7.75e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—MTHFR—Alzheimer's disease	9.09e-06	7.71e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NOS3—Alzheimer's disease	8.94e-06	7.58e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—BCHE—Alzheimer's disease	8.66e-06	7.35e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6—Alzheimer's disease	8.5e-06	7.21e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CALM1—Alzheimer's disease	8.49e-06	7.2e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APOE—Alzheimer's disease	8.46e-06	7.17e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CAV1—Alzheimer's disease	8.38e-06	7.11e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	8.17e-06	6.93e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	7.92e-06	6.72e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT1—Alzheimer's disease	7.84e-06	6.65e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPARG—Alzheimer's disease	7.37e-06	6.25e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—INS—Alzheimer's disease	7.23e-06	6.13e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TGFB1—Alzheimer's disease	7.06e-06	5.99e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AKT1—Alzheimer's disease	6.97e-06	5.91e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	6.83e-06	5.79e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	6.8e-06	5.76e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NOS3—Alzheimer's disease	6.34e-06	5.37e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LPL—Alzheimer's disease	6.22e-06	5.27e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKT1—Alzheimer's disease	6.15e-06	5.22e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS2—Alzheimer's disease	5.8e-06	4.92e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	5.6e-06	4.75e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6—Alzheimer's disease	5.32e-06	4.51e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CALM1—Alzheimer's disease	5.23e-06	4.44e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APOE—Alzheimer's disease	5.21e-06	4.42e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CAV1—Alzheimer's disease	5.16e-06	4.38e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT1—Alzheimer's disease	4.91e-06	4.16e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPARG—Alzheimer's disease	4.54e-06	3.85e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—INS—Alzheimer's disease	4.45e-06	3.78e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKT1—Alzheimer's disease	4.11e-06	3.49e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.9e-06	3.31e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	3.57e-06	3.03e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKT1—Alzheimer's disease	2.91e-06	2.47e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.79e-06	1.52e-05	CbGpPWpGaD
